[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"anorexia-nervosa-atypical\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:anorexia-nervosa-atypical":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,53,83],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100478383","early-phase-1-naltrexone-neuroimaging-in-teens-with-eating-disorders-100478383",false,"NCT05509257","Naltrexone Neuroimaging in Teens With Eating Disorders","Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents With Eating Disorders","NN-RCT","Inclusion Criteria:\n\n* Adolescents and young adults aged 13-21 years\n* Eating disorder diagnosis characterized by binge eating and\u002For purging (eg, Anorexia Nervosa-Binge\u002FPurge, Bulimia Nervosa, Binge Eating Disorder, Other Specified Feeding\u002FEating Disorder) using Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V) criteria.\n* Stable medication regimen (no dose or drug changes in the past 4 weeks)\n* Participant and parent\u002Flegal guardian (if under 18 years) are willing and able to provide informed permission\u002Fassent\u002Fconsent for the study\n\nExclusion Criteria:\n\n* Pregnant (via UCG)\n* Prior hypersensitivity reaction to naltrexone (e.g., anaphylaxis)\n* Non-removable metal in the body that is magnetic resonance imaging incompatible\n* Current naltrexone use\n* Self-reported opioid use in the past 7 days\n* A language barrier (e.g., non-English speaking) for the participant that precludes communication and\u002For ability to complete all study-related requirements.","ALL","13 Years","21 Years",{"count":21,"type":22},60,"ESTIMATED","INTERVENTIONAL",[25],"EARLY_PHASE1","Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders. The hypothesis is that fMRI will be able to detect acute reward pathway modulation by naltrexone (an opioid antagonist) in pre-defined regions of interest (anterior cingulate cortex, nucleus accumbens, dorsolateral prefrontal cortex).",[28,29,30,31,32],"Eating Disorders","Binge Eating","Purging (Eating Disorders)","Bulimia Nervosa","Anorexia Nervosa, Atypical",[34,35,36,37,38,39],"Pediatric","Adolescent","Eating Disorder","Neuroimaging","Naltrexone","Pharmacodynamic Biomarker","RECRUITING","2025-11-20",{"date":43,"type":44},"2025-11-25","ACTUAL",{"date":46,"type":44},"2022-09-17",{"date":48,"type":22},"2027-06",{"name":50,"class":51},"Children's Mercy Hospital Kansas City","OTHER",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":59,"minAge":18,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":4,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":52},"100605234","frequency-of-hypermobility-related-problems-in-patients-with-anorexia-nervosa-100605234","NCT07159867","Frequency of Hypermobility-Related Problems in Patients With Anorexia Nervosa","Inclusion Criteria:\n\nFemale patients Aged 13-25 years\n\nDiagnosed with:\n\n* Anorexia Nervosa (ICD-10 F50.0), or\n* Atypical Anorexia Nervosa (ICD-10 F50.1)\n* Currently receiving treatment or scheduled to receive treatment\n\nExclusion Criteria:\n\n* Severe cognitive impairment\n* Insufficient Swedish language skills that make it impossible to provide informed consent and prevent answering study questions\n* Pregnancy and up to one year postpartum","FEMALE","25 Years",{"count":62,"type":22},100,"OBSERVATIONAL","The purpose of this study is to examine the frequense of generalized hypermobility and pain in patients with Anorexia Nervosa. The study further explores two main questions: (1) whether generalized hypermobility may be an explanatory factor for pain in some patients with Anorexia Nervosa, and (2) whether temporomandibular joint problems (such as instability, pain, difficulties opening the mouth, locking, or clicking) contribute to eating difficulties in certain individuals with Anorexia Nervosa.",[32,66],"Anorexia Nervosa",[68,69,70,71],"Anorexia nervosa","Joint hypermobility","Pain","Temporomandibular joint","NOT_YET_RECRUITING","2025-08-28",{"date":75,"type":44},"2025-09-08",{"date":77,"type":22},"2025-09-15",{"date":79,"type":22},"2026-07-30",{"name":81,"class":82},"Vastra Gotaland Region","OTHER_GOV",{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":17,"minAge":91,"maxAge":92,"enrollmentInfo":93,"targetDuration":4,"studyType":23,"phases":95,"briefSummary":97,"conditions":98,"keywords":100,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":52},"100576959","evaluation-of-radically-open-dialectical-behavior-therapy-for-youth-at-risk-for-developing-severe-and-enduring-eating-disorders-100576959","NCT06792071","Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders","Feasibility and Efficacy of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders","RO-SEED","Inclusion Criteria:\n\n* Being 14-19 years old\n* Primarily restrictive eating disorder symptoms that remain despite at least one previous treatment attempt.\n* Problems related to maladaptive overcontrol\n* Written informed consent (for minors, this includes consent from all caregivers and the minors themselves).\n\nExclusion criteria:\n\n* Eating disorders symptoms in need of emergency care\n* High risk for suicide\n* An inability to respond to the questionnaires or participate in the skills class, e.g., due to lack of knowledge in Swedish.","14 Years","19 Years",{"count":94,"type":22},18,[96],"NA","The goal of this experimental interventional study is to learn if the psychological treatment Radically Open Dialectical Behavior Therapy (RO-DBT), is feasible to conduct and provide positive effects for adolescents with eating disorders and emotional overcontrol. Participants will be those at risk for developing severe and enduring eating disorder symptoms, as they have not responded fully to previous treatment attempts.\n\nPrimary outcomes are feasibility and changes in eating disorder symptoms. Secondary outcomes are changes in unhelpful behaviors and experiences related to emotional overcontrol; including psychological inflexibility, suppression of emotions, and experience of loneliness.\n\nThe participants will undergo the treatment with RO-DBT, which include an approximately 22 week long treatment consisting of individual psychotherapy and parallel skills training in group.",[28,66,32,99],"Feeding and Eating Disorders",[66,101,102,103],"Eating disorders","Radically open dialectical behavior therapy","Single-case experimental design study","2025-01-19",{"date":106,"type":44},"2025-01-24",{"date":108,"type":22},"2025-02",{"date":110,"type":22},"2027-07",{"name":112,"class":51},"Uppsala University Hospital"]